Lanza Robert

Avg. Two Year Performance

No purchase track record

70% Avg. Sale Return

30% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	6%	22%	26%	49%	70%
Sale Success Rate	8 of 14	11 of 14	6 of 14	5 of 14	10 of 14

Advanced Cell Technology Inc.

Drugs » Biotechnology

Chief Scientific Officer:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--